Yale Program in Addiction Medicine physicians and advanced practice providers prevent, diagnose, and treat substance use disorders and related harms. Our program, founded on over 30 years of pioneering research designed to integrate addiction treatment into general medical settings, is internationally recognized for leadership in the field and innovative approaches to care. Our clinicians are experienced in treating opioid, alcohol, tobacco, and other substance use disorders and in providing medications and behavioral therapy for substance use treatment. Our clinicians have training in a wide range of areas in medicine including internal medicine, primary care, emergency medicine, pediatrics, infectious diseases, psychiatry, pulmonary and critical care medicine. They are experienced in providing treatment for substance use alongside pregnancy and care for other co-occurring conditions such as pain, Hepatitis C, HIV, bacterial infections, and mental health diagnoses. Yale Program in Addiction Medicine clinicians see patients in community health centers, primary care clinics, infectious disease clinics, the emergency department, and in the hospital. We emphasize a patient-centered approach to care and will work with patients and their families to identify a treatment plan that best supports the patient’s needs and goals. Our clinicians meet patients where they are—whether they are new to treatment, returning to treatment, or exploring ways to reduce risk associated with substance use. Our dedicated clinicians are experienced in treating the full spectrum of substance use from intermittent use to severe substance use disorder. We use evidence-based treatment strategies to care for patients throughout the often relapsing-remitting nature of the disease of addiction and are supported by a large community of experts in the field working to develop and make available innovative, effective treatment options. In collaboration with our many community-based and institutional partners, we offer a robust network of care options to ensure appropriate support for our patients at every stage of treatment. Yale School of Medicine is a teaching institution. As such, patient care teams may include physician fellows, residents, advanced practice trainees, and or medical students being trained by our program in addiction medicine. The Yale Program in Addiction Medicine houses a robust research portfolio focused on advancing innovative treatments and improving the quality and efficacy of care for our patients. We are internationally recognized for our scholarly contributions to the field, particularly with respect to implementation and evaluation of medications for substance use treatment in primary care clinics, infectious disease clinics, the emergency department, and in the hospital, as well as comprehensive training and education of the next generation of addiction medicine providers. Our faculty and collaborators form an interdisciplinary team representing intern

Yale Psychiatry is the largest provider of psychiatric services in Connecticut, and the top National Institutes of Health-supported Department of Psychiatry in the United States. We are dedicated to adding to the body of knowledge in the field, and improving treatments for psychiatric disorders that span all ages. This includes helping people cope with major life events or medical illnesses, behavioral problems associated with personality disorder or addiction, mood and psychotic disorders, and dementia. Yale investigators have pioneered new treatments for nearly every psychiatric disorder. Our research programs have produced breakthroughs in areas as diverse as molecular neuroscience, genetics, translational neuroscience, neuroimaging, psychopharmacology, psychotherapy, rehabilitation, health services, forensic psychiatry, epidemiology, and health policy. Today, our clinicians are at the forefront of social, pharmacological, psychological, rehabilitative, and neurostimulation treatments. Through clinical trials, our interventional psychiatry service delivers high-impact treatments, including ECT (electroconvulsive therapy) and ketamine, for patients with treatment-resistant symptoms of depression. Our clinical programs are interwoven with our research efforts. We host programs that specialize in the major mental diseases and substance abuse treatment at three major institutions: Connecticut Mental Health Center, the Veterans Affairs Connecticut Healthcare System, and the Yale New Haven Psychiatric Hospital. We also provide increased psychiatry support for Smilow Cancer Hospital in areas such as smoking cessation.

The physicians in our General Internal Medicine section are national leaders in their fields, and provide dedicated, comprehensive patient care in both inpatient and outpatient settings at several sites across Connecticut: At Yale Internal Medicine Associates in New Haven, we provide state-of-the-art general medical care for adults. At the New Haven Primary Care Consortium (NHPCC), located at 150 Sargent Drive in New Haven, CT, we provide comprehensive primary care, as well as specialized programs in traveling health, rheumatology, dermatology, podiatry, mental health, and addiction medicine. The Occupational and Environmental Medicine clinic focuses on the diagnosis, treatment, and prevention of diseases due to chemical, biological, and physical hazards in the workplace and environment. The Primary Care Center located at the VA Connecticut Healthcare System in West Haven is also a major clinical and teaching site, and provides specialized Women’s Health and stroke care. The Medicine-Pediatric Clinic is located at St. Mary’s Hospital, 133 Scovill Street, in Waterbury. The Yale Addiction Medicine Consult Services provide hospital-based addiction assessment and treatment to patients who are hospitalized at Yale New Haven Hospital. Specialized programs in dermatology, mental health, rheumatology, and health care for travelers Medical forensic exams for individuals with claims of torture who are seeking asylum in the U.S. Specialized program for the treatment of substance use disorders We are also involved in community outreach and service programs that expand the reach of our research and clinical programs. Our research programs in such areas as substance abuse, occupational medicine, and chronic disease management provide our patients in the community with a variety of opportunities to access care and improve their health. Many of our faculty members are graduates of the Robert Wood Johnson Clinical Scholars Program.